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Abstracts / Osteoarthritis and Cartilage 23 (2015) A82eA416 A305high blood glucose levels, suggesting a link between blood glucose and
severe OA, as has been suggested previously. BMLs detected with spe-
ciﬁc MRI sequences may act as potential MRI biomarkers for identi-
ﬁcation of individuals at high risk of progressive OA and inform
development and monitoring of new therapies.
Figures A, B, C, D represent signiﬁcant difference between groups.
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GENE EXPRESSION ANALYSIS AND DNA METHYLATION IN THE
PROMOTER REGION OF MATRIX METALLOPROTEINASE e 13 (MMP-
13) AND OSTEOARTHRITIS
P.E. Harper, M. Liu, E. Aref-Eshghi, G. Martin, A. Furey, R. Green,
P. Rahman, G. Zhai. Mem. Univ. of Newfoundland, St John's, NL, Canada
Purpose: Osteoarthritis (OA) is a progressive, chronic condition char-
acterized by focal damage to articular cartilage, chronic inﬂammation
and alterations to the extracellular matrix, leading to pain, stiffness and
a loss of physical function. OA's initiation and progression are caused by
various environmental and genetic factors. One common factor
believed to play a signiﬁcant role in OA is environmentally-triggered
epigenetic alterations, speciﬁcally DNA methylation. Of particular
interest in the study of OA is the loss and degradation of collagen caused
by matrix metalloproteinase e 13 (MMP-13). Several studies have
examined the association between OA and methylation in MMP-13.
Furthermore, MMP-13 has been suggested as a potential therapeutic
target for OA treatment. However, these studies have reported con-
ﬂicting results. The aim of this study was to determine the gene
expression and potential corresponding methylation levels in the pro-
moter region of MMP-13 in patients diagnosed with hip OA versus
healthy controls.
Methods: A hospital-based case-control study design was utilized.
Cartilage samples were collected from patients undergoing total hip
replacement due to primary hip OA and hip fracture patients who
required a hemiarthroplasty but did not have evidence of OA. RNA and
DNA were extracted from the same cartilage samples. MMP-13
expression was examined from RNA using real-time quantitative PCR.
Using DNA, methylation levels of seven CpG sites located in the pro-
moter region of MMP-13 (up to 600 bp from the ﬁrst exon) were
assayed using Sequenom EpiTYPER. This method uses mass spectrom-
etry to separate methylated and non-methylated DNA segments into
distinct signals.
Results: A total of 38 subjects were included in the analysis, 23 patients
diagnosed with hip OA (13 females, 10 males) and 15 healthy controls
(12 females, 3 males). The mean age was 63 in OA cases and 77 in
controls. Our gene expression analysis indicated that OA patients had a
ﬁve-fold increase in MMP-13 expression compared to controls. This
difference was statistically signiﬁcant with a p-value of 0.0095, based
on student's T-test. Due to the skewed distribution of the gene
expression data, this signiﬁcance was veriﬁed using Mann-Whitney
test. Among the 7 CpG sites in the MMP-13 promoter region analyzed,
we found one site with signiﬁcantly altered methylation pattern in OA
patients versus controls. The CpG site 218 bp upstream of the ﬁrst exon
showed a trend towards lower methylation in OA patients at an average
of 44% versus controls at 57%, with a p-value of 0.009. This methylation
level was signiﬁcantly correlated with gene expression in OA cases, with
a correlation coefﬁcient of 0.55 and a corresponding p-value of 0.0068
based on Spearman's rank correlation. This correlation was not seen in
controls however. Furthermore, we found that methylation was con-
founded by age with a trend toward increasing methylation corre-
sponding with advancing age.
Conclusions: This study demonstrates a signiﬁcant difference in the
gene expression levels of MMP-13, with OA patients having a higher
level of MMP-13 expression. In addition, a hypomethylated CpG site in
the promoter region of MMP-13 was found in OA patients versus con-
trols, implicating this CpG site as one potential regulatory site for MMP-
13 gene expression. The ﬁnding was confounded by age, indicating that
methylation at this site could be a potential intermediate factor in
advancing OA. We hypothesize that increasing methylation with
advancing age in MMP-13 may serve as a protective mechanism to
prevent collagen degradation. A validation study is needed to conﬁrm
the ﬁndings.480
EVALUATION OF TIBIOFEMORAL CARTILAGE CONTACT AREA
ALTERATIONS IN ANTERIOR CRUCIATE LIGAMENT INJURED PATIENTS
E. Chen, K. Amano, V. Pedoia, R. Souza, C. Ma, X. Li. Univ. of California,
San Francisco, San Francisco, CA, USA
Purpose: Anterior cruciate ligament (ACL) injuries cause changes in
tibiofemoral joint kinematics and can lead to early onset of osteo-
arthritis (OA) despite surgical reconstruction. Changes in kinematics
may alter the contact area (CA) between the femoral and tibial cartilage
surfaces. Evaluations of the tibiofemoral CA in ACL injured individuals
can help understand the mechanism behind cartilage degeneration
seen after ACL injury and reconstruction. The purpose of this study was
to determine the changes in tibiofemoral CA and their positions at the
time of injury and after reconstruction.
Methods: Subjects: Bilateral knee MRI scans of thirty healthy adults (15
males, age¼ 28.93 ± 7.81 years, BMI¼ 23.44 ± 2.74 kg/m2) with isolated
unilateral ACL injuries were obtained within 6 months of their injury
(i.e. baseline) prior to surgery and again at 1 year after ACL recon-
struction. Fourteen healthy control subjects (10 males, age ¼ 31.78 ±
4.80 years, BMI ¼ 24.01 ± 2.26 kg/m2) with no history of knee injuries
were recruited for comparison. Exclusion criteria included prior diag-
nosis of cartilage degeneration, inﬂammatory arthritis, or surgery in
either knee.
MRI Protocol: Subjects' knees were scanned with a 3 Tesla MRI scanner
(GE Healthcare, Milwaukee, WI, USA) with an 8-channel phased array
knee coil (Invivo, Orlando, FL, USA). Sagittal T2 fast spin-echo (FSE)
images with TR/TE ¼ 4000/49.3 ms, slice thickness of 1.5 mm, ﬁeld of
view of 16 cm, 512 x 512 matrix size and echo train length 9 were
obtained at extension, loaded axially with of 25% total body weight.
Image Processing: Regions of interest were delineated in FSE images
with an in-houseMatlab program using a spline-based semi-automated
segmentation algorithm. The midpoint between the tibial medial and
lateral posterior cortical border was deﬁned as the origin of the tibial
coordinate system. Tibiofemoral cartilage CA was deﬁned as the weight
bearing regions on the tibial surface (Figure 1). Fluids indicated by
hyperintensity and menisci were excluded along with areas close to the
tibial spine. CA centroid position (CP) was deﬁned as the geometric
center of CA projected onto the axial plane. The ﬂexion angle (FA) was
deﬁned by the angle between the lines through the midshaft of femur
and tibia in the anteroposterior (AP) direction. A single observer pro-
cessed all MR images and all measurements were taken in the extended
position.
Statistical Analysis: Reliability was measured using Intraclass Correla-
tion coefﬁcient (ICC) over three trials of 10 control subjects. Differences
in mean CA and CP between groups and longitudinal changes from
baseline to 1 year were measured with a Student's t-test. Signiﬁcance
was deﬁned as P<0.05 for all analyses.
Results: Reliability: The intra-operator ICC's were 0.922 and 0.942 for
medial and lateral CA respectively, and 0.996 and 0.996 for medial and
lateral CP.
Contact Area: Medial CA was larger in injured knees compared to
control knees at both time points and the difference reached sig-
niﬁcance at one year (P¼0.036). For the medial CA, there were sig-
niﬁcant differences between contralateral and control knees at baseline
and one year (P¼0.043 and P¼0.008). There was no signiﬁcant differ-
ence between injured and contralateral knees at the two time points
(Table 1).
Centroid Position: CP along the AP direction was signiﬁcantly more
posterior for the injured knees compared to the contralateral knees at
baseline for both medial and lateral regions (P¼0.001 and p¼0.043). No
signiﬁcant difference was found between injured and control knees or
between contralateral and control knees (Table 2).
Conclusions: ACL injured subjects had increased in the medial CA for
both injured and contralateral knees compared to the controls. The
difference between contralateral and control knees suggests that there
may be inherent differences in knee kinematics of ACL injured patients.
Lack of signiﬁcant difference in CA between the two time points indi-
cates that reconstruction did not restore CA and knee kinematics.
Overall, the result of the study shows altered knee kinematics in those
with ACL injuries. Increased CA may indicate changes in knee kine-
matics that could lead to ACL tears and OA.
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